Hemopericardium with subsequent cardiac tamponade secondary to rivaroxaban treatment: a case report.

ABSTRACT:

Background

The use and utility of novel oral anticoagulants has been increasing in clinical practice due to their relatively lower incidence of side effects such as intracranial haemorrhage, particularly in the elderly, when compared with vitamin K antagonists. Rivaroxaban is a factor Xa and prothrombinase inhibitor indicated for stroke and venous thromboembolism prophylaxis in non-valvular atrial fibrillation as well as treatment of venous thromboembolism.

Case summary

A patient with history of paroxysmal atrial fibrillation on Rivaroxaban presented with generalized malaise, lightheadedness, and dizziness. The patient was found to be in profound cardiogenic shock despite unremarkable cardiac enzymes. Electrocardiogram revealed rate controlled atrial fibrillation and T-wave

SUBMITTER: Shastri P 

PROVIDER: S-EPMC7898561 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature